In March 2025, the company declared new designs for the direct-to-purchaser featuring of its Wegovy weight loss drug. The company established a fresh pharmacy, named NovoCare, which might cost clients $499 each month for entry to the drug, less than half the price of the drug through other pharmaceutical distribution networks.[fifty three]However,